To validate the predictive capacity of KLF5 in tumor immunotherapy, we performed ROC analysis of pan-cancer immunotherapy cohorts from the GEO database, demonstrating its modest predictive efficacy for immunotherapeutic response (Figure 7B). Here, KLF5 is linked to neoplasm.